We're proud to support this important effort to tackle the pressing global public health crisis of antimicrobial resistance. #AMR
Cuts to the R&D tax credit in California would have a chilling effect on lifesaving R&D to improve patient care, putting CA's global leadership in biomedical innovation at risk.
We're proud to do our part to support global communities affected by #COVID19, including in Singapore.
Like many U.S. companies in Singapore, @Amgen has made monetary and in-kind donations to healthcare workers, frontline professionals, and volunteers. It has also encouraged people under Stay-Home Notices during COVID-19 to maintain active lifestyles by donating resistance bands.
We are committed to doing our part in this historic fight – not just through our words, but through our actions.
Tuesday, 6/23: Dr. Cathy Critchlow, VP of R&D Data Strategy at Amgen, joins @Fierce Life Sciences Events Virtual Series for a discussion with @FiercePharma @Boehringer Ingelheim @Biogen and @Massachusetts Institute of Technology (MIT) on real-world evidence and the effect of #COVID19 on the clinical trial model. #FierceClinicalTrials